SEC Filings

Filing date	Form	Description	Filing Group	View
February 15, 2024	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	View HTML 0001104659-24-024545.pdf 0001104659-24-024545.rtf 0001104659-24-024545.xls
January 13, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-003636.pdf 0001104659-23-003636.rtf 0001104659-23-003636.xls
January 25, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-006384.pdf 0001104659-23-006384.rtf 0001104659-23-006384.xls
February 3, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-010230.pdf 0001104659-23-010230.rtf 0001104659-23-010230.xls
February 16, 2024	SC 13G/A	An amendment to the SC 13G filing	Other	View HTML 0001104659-24-024912.pdf 0001104659-24-024912.rtf 0001104659-24-024912.xls
January 13, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-003637.pdf 0001104659-23-003637.rtf
January 25, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-006388.pdf 0001104659-23-006388.rtf
February 2, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-009560.pdf 0001104659-23-009560.rtf 0001104659-23-009560.xls
December 28, 2022	CORRESP	CORRESP	Other	View HTML 0001104659-22-130318.pdf 0001104659-22-130318.rtf
May 31, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-066352.pdf 0001104659-23-066352.rtf 0001104659-23-066352.xls

Data provided by Kaleidoscope.

Print Page

Email Alerts

RSS Feeds

Contact IR

Site Map Terms of Use Privacy

Contact Info

YS Biopharma Co., Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +1 (301) 208 8823
Fax: +1 (301) 208 8827

bjinfo@yishengbio.com